Discover more from Palantir Bullets
🚨 "I am Mr. Palantir" | Bullets #51
Editor: Emanuele Marabella
Hi, I’m Arny 👋 If you want to talk about Palantir with me and other passionate investors, join my community on Patreon.
It’s only $5 per month and that would support my research for you 😊
David Davis, Conservative Member of Parliament, shared his skepticism on Palantir at the Parliament, arguing that “even if it behaved perfectly, nobody would trust it.”
However, the following day, the website DigitalHealth.net, disclosed that the NHS procurement has now been signed off by ministers. It should only be a matter of days before the final announcement. Will this be the end of the saga?
Palantir stock rose +7% to $19 the day after this NHS update spread. I had the opportunity to discuss Palantir’s valuation at Palantir Weekly Podcast #99 hosted by Amit:
Time Magazine wrote an article explaining how Ukraine is using AI to help clear Russian landmines.
“Palantir and Ukrainian agencies worked together to develop a platform that combined data from government agencies, including the Ministries of Education, Defense, Agriculture, Energy, and Infrastructure, with information like cell phone data from Ukrainian mobile operators, which can reveal how many people are actually living in an area or using certain roads.” Time
Palantir Apollo is now available for free trials. I shared what Apollo is and why it is crucial, in the article below.
Palantir Head of Public Health participated at the Milken Institute Future of Health Summit explaining how crucial it is to integrate data in order to make sense of it.
Palantir CTO Shyam Sankar participated at the Defense & Aerospace Daily Podcast discussing Biden’s executive order on AI, the Pentagon procurement and the new generation of military tech companies.
Jim Cramer, CNBC, professes himself as “Mr. Palantir.” Back in May, he defined Palantir as “not a real company” and the stock doubled since. Should investors be worried?
Tweet of the week
RBC’s Analyst is still convinced.
You can also reach me at:
Disclaimer: The views and opinions expressed above are current as of the date of this document and are subject to change without notice. Materials referenced above will be provided for educational purposes only. None of the above will include investment advice, a recommendation or an offer to sell, or a solicitation of an offer to buy, any securities or investment products.
Thanks for reading Palantir Bullets! Subscribe for free to receive new posts and support my work.